Treatment of Central Nervous System Tuberculosis Infections and Neurological Complications of Tuberculosis Treatment
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
2940-2947
Author(s):
J. J. van der Harst and G. J. Luijckx
Gene Therapy for Parkinsons and Alzheimers Diseases: from the Bench to Clinical Trials
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
3434-3445
Author(s):
Rui Jorge Nobre and Luis Pereira de Almeida
Targeting Mitochondrial Bioenergetics for Alzheimers Prevention and Treatment
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
3474-3479
Author(s):
Jia Yao and Roberta Diaz Brinton
Porphyrin Photosensitised Processes in the Prevention and Treatment of Water- and Vector-Borne Diseases
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
808-819
Author(s):
O. Coppellotti, C. Fabris, M. Soncin, M. Magaraggia, M. Camerin, G. Jori and L. Guidolin
Approaches to Minimize Infection Risk in Blood Banking and Transfusion Practice
Journal:
Infectious Disorders - Drug Targets
Volume:
11
Page:
45-56
Author(s):
Paul F. Lindholm, Kyle Annen and Glenn Ramsey
DNA Microarrays - An Armory for Combating Infectious Diseases in the New Century
Journal:
Infectious Disorders - Drug Targets
Volume:
6
Page:
263-279
Author(s):
T. Chen
Serial Analysis of Gene Expression in Eukaryotic Pathogens
Journal:
Infectious Disorders - Drug Targets
Volume:
6
Page:
281-297
Author(s):
James W. Kronstad
Intracellular Amyloid β-Protein and Its Associated Molecules in the Pathogenesis of Alzheimers Disease
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
6
Page:
1075-1080
Author(s):
Yasumasa Ohyagi and Takeshi Tabira
Current Status Of Short Synthetic Peptides As Vaccines
Journal:
Medicinal Chemistry
Volume:
2
Page:
627-646
Author(s):
Dhiraj Hans, Paul R. Young and David P. Fairlie
Disrupting β-Amyloid Aggregation for Alzheimer Disease Treatment
Journal:
Current Topics in Medicinal Chemistry
Volume:
7
Page:
115-126
Author(s):
L. D. Estrada and C. Soto